Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).

Document Type

Journal Article

Publication Date

3-1-2019

Journal

Lancet Haematology

Volume

6

Issue

3

Inclusive Pages

e132-e143

Keywords

10.1016/S2352-3026(18)30221-7

Peer Reviewed

1

This document is currently not available here.

Share

COinS